Olygose SAS

Olygose SAS

Olygose SAS

Date Founded



Parc Technologique Rives de l'Oise,rue Les Rives de l'Oise,Venette, Picardie (Picardy) 60280

Type of Company



Commercial Scientific Research
Other Business & Consulting Services
Medical Products & Equipment
Holding Companies

Company Description

Olygose SAS supplies ingredients for food and health industry. It offers extraction and purification of soluble fibers from legumes. It offers CravingZ'Gone, a satiety ingredient for weight management control and AlphaGOS, a sugar replacement. The company was founded in 2009 and is headquartered in Venette, France.

Paths to Olygose SAS
Potential Connections via
Relationship Science
Olygose SAS
Details Hidden

Emertec is an early-stage venture capital investor focused on industries based on engineering sciences. The firm targets innovative high-technology companies and invests in sectors including microelectronics, microsystems, embedded software, electronic design automation, advanced materials such as semiconductors, metrology and monitoring equipment, robotics, energy and environmental sciences.Emertec provides seed capital in the first round of financing and later participates in subsequent rounds over several years of the company's early expansion. The firm invests in France and in neighboring EC countries, either as sole investor or in syndication, in which case they favor deals including a local co-investor. They generally acquire minority stakes and do not use leverage. The firm's deal flow originates from incubation structures, in particular divisions of CEA, and from private or publicly-funded research institutions in France and Europe.

Details Hidden

Founder at Olygose SAS

Details Hidden

Sopartec is an active venture capital investment manager focused on early-stage technology companies emerging from research done at UCL. They help academic researchers develop and protect UCL's IP and identify potential industrial partners. The firm provides consulting support throughout the development of their portfolio companies.Sopartec generally acts as the lead investor. Their VIVES seed fund is aimed at stimulating the creation and growth of university spin-offs. The fund is also invested in existing early-stage technology companies selected for strategic partnership purposes. Sopartec acquires minority stakes in existing technology companies whose technology complements products or services developed by their portfolio companies. These investments may consist of participations in spin-offs from other universities.